Metronics Introduces Brain-Stimulation Implants
By wchung | 24 Mar, 2026
Medtronic Inc. said Tuesday it began marketing two surgically implanted devices that are intended to help relieve symptoms for patients with neurodegenerative diseases.
The Minneapolis company said it is now marketing the Activa RC and Activa PC neurostimulators in Canada, and the first implantation of the new device has already taken place. The products are intended to reduce symptoms by stimulating the brain electronically.
Medtronic said the devices have new programming options, are smaller than its older models, and feature rechargeable batteries that can last up to nine years before a replacement is needed. The neurostimulators are used to treat conditions like Parkinson’s disease and tremors.
In afternoon trading, Medtronic shares added 65 cents to $43.09.
2/16/2010 1:30 PM NEW YORK (AP)
Articles
- NASA to Spend $20 Billion on Moon Base, Cancel Lunar Orbit Station
- Pakistan Offers to Host Actual Peace Talks—IRL
- Mandopop Legend Jay Chou to Release First Album in 4 Years
- Japan's Cherry Blossom Picnics Pinched by 25% Food Inflation Since 2020
- SK Hynix Places Record $8 Billion Order for ASML EUV Lithography Tools
- TSMC Capacity a Major Bottleneck for AI Buildout Says Broadcom
- BTS Army to Bring $5.3 Billion Spending Power to a City Near You
- Zoox to Expand Robotaxi Service into San Francisco and Las Vegas
- NYSE Partners with Securitize to Develop Tokenized Securities Platform
- World's 25 Most Polluted Cities All in India, Pakistan and China